TrialScientific reports2020

Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer.

Francesco Pantano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.